Insulin resistance in type 2 diabetic Nigerians

International Journal of Diabetes and Metabolism

Volumn 13, Issue 1, 2005, Pages 24-27

  Bakari, Adamu Girei ^a   Onyemelukwe, Geoffrey C ^a  

^a AHMADU BELLO UNIVERSITY   (Nigeria)

Author keywords

HOMA; Insulin resistance; Nigerians; Type 2 diabetes

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ETHNOLOGY; FEMALE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NIGERIA; NON INSULIN DEPENDENT DIABETES MELLITUS; RACE DIFFERENCE; SOCIAL STATUS; STATISTICAL ANALYSIS;

EID: 33645959177     PISSN: 16067754     EISSN: None     Source Type: Journal    
DOI: 10.1159/000497570     Document Type: Article

References (19)

1. World Health Organization. Definition, Diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation, WHO; Geneva, 1999.
2. Martin BC, Warram JH, Krowleski AS, et al. Role of glucose and insulin resistance in the development of type 2 diabetes mellitus: results of a 25 year follow up study. Lancet 1992; 340:925-929.
3. Banerji MA, Lebovitz H. Insulin sensitive and insulin resistant variants in NIDDM. Diabetes 1989; 38:784-792.
4. Bonora E F, Formentini G, Calcaterra F et al, HOMA estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona diabetes study. Diabetes Care 2002; 25:1135-1141.
5. Williams G. Management of non-insulin dependent diabetes mellitus. Lancet 1994; 343:95-100.
6. Omar MAK, Asmal AC. Insulin responses to oral glucose in young African and Indian non- insulin dependent diabetic patients in Natal. Trop Geog Med 1983; 35:59-64.
7. World Health Organization Expert committee: Physical status; the use and interpretation of anthropometry. Report of a WHO expert committee. Technical report series 854, WHO Geneva, 1995.
8. Verstraete M. Clinical applications of inhibitors of fibrinolysis. Drugs 1985; 29:236-261.
9. Trinder P. Determination of Glucose in blood using glucose-oxidase with an alternative oxygen acceptor. Ann Clin Biochem 1969; 6:24-27.
10. Matthews DJ, Hoskers JP, Rudenski AS, Waylur BA, Trencher DY, Turner RC Homeostasis model assessment Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-419.
11. Defronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237:E214-E223.
12. Defronzo RA Glucose intolerance of aging evidence for tissue insensitivity to insulin. Diabetes 1979; 28:1095-1 101.
13. Reaven GM, Hollenbeck CB, Chen YD. Relationship between glucose intolerance, insulin secretion, and insulin action in non obese individuals with varying degrees of glucose intolerance Diabetologia 1989; 32:52-55.
14. Bonora E, Saggiani F, Targher G, et al. Homeostasis Model Assessment closely mirrows the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care 2000; 23:23-25.
15. Adadevoh BK. Endocrine pattern of the African: Clinico-Biochemical assessment Trop Geog Med 1970; 22:125-141.
16. Adadevoh BK, Emuruem DSC, Ihenacho HNC, et al. Tolerance to insulin by Nigerians. West Afr Med J 1968; 17:93-95.
17. Nagulesparan M, Savage PJ, Knowler WC, et al. Increased in vivo insulin resistance in non diabetic Pima Indiana compared with Caucasians. Diabetes, 1982; 31: 952-956.
18. Rosetti L, Glaccari A, Defronzo RA. Glucose toxicity. Diabetes Care 1990; 13:610-630.
19. Unger RH, Grundy S. Hyperglycaemia as an inducer of as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes. Diabetologia 1985; 28:110-121.